Drug Shortage Report for TARO-CLARITHROMYCIN

Last updated on 2024-02-14 History
Report ID 167868
Drug Identification Number 02390442
Brand name TARO-CLARITHROMYCIN
Common or Proper name CLARITHROMYCIN
Company Name TARO PHARMACEUTICALS INC
Market Status MARKETED
Active Ingredient(s) CLARITHROMYCIN
Strength(s) 125MG
Dosage form(s) GRANULES FOR SUSPENSION
Route of administration ORAL ORAL
Packaging size 105
ATC code J01FA
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-07-13
Estimated end date 2024-01-12
Actual end date 2024-01-10
Shortage status Resolved
Updated date 2024-02-14
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 130 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v56 2024-02-14 English Compare
v55 2024-02-08 French Compare
v54 2024-02-08 English Compare
v53 2024-01-05 French Compare
v52 2024-01-05 English Compare
v51 2023-10-25 French Compare
v50 2023-10-25 English Compare
v49 2023-09-25 French Compare
v48 2023-09-25 English Compare
v47 2023-09-22 French Compare
v46 2023-09-22 English Compare
v45 2023-08-30 French Compare
v44 2023-08-30 English Compare
v43 2023-08-16 French Compare
v42 2023-08-16 English Compare
v41 2023-07-18 French Compare
v40 2023-07-18 English Compare
v39 2023-06-09 French Compare
v38 2023-06-09 English Compare
v37 2023-05-15 French Compare

Showing 1 to 20 of 56